BeOne Medicines Q1 2026 revenue rises 35% year over year to $1.5B, raises full-year 2026 revenue and operating income guidance
https://finviz.com/quote?t=ONC&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.